Fisher Wallace Laboratories, Inc. — Form D
Fisher Wallace Laboratories, Inc. of BROOKLYN, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-13. The offering totals $5.0M. Industry: Biotechnology.
Offering
- Filed: 2025-06-13
- Form: D
- Accession: 0001787792-25-000005
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $5.0M
- Remaining: $5.0M
- Minimum investment: $3K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-548894
Issuer
- Name: Fisher Wallace Laboratories, Inc.
- CIK: 0001787792
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 630 FLUSHING AVENUE, BOX 104, BROOKLYN, NY, 11206
- Phone: 917-930-4332
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Charles Avery Fisher | Director | BROOKLYN, NY |
| Kelly Joseph Roman | Director | BROOKLYN, NY |
| Kelly Joseph Roman | Executive Officer | BROOKLYN, NY |
| Charles Fisher | Director | San Francisco, CA |
| Charles Fisher | Executive Officer | San Francisco, CA |
| Simon Webster | Director | Jersey, Y7 |
| Kelly Roman | Director | Brooklyn, NY |
| Kelly Roman | Executive Officer | Brooklyn, NY |
Other filings by this issuer (1)
More